U.S. Energy Services Stock News

NYSE:USFD
NYSE:USFDConsumer Retailing

US Foods Reworks Deal Playbook After Shetakis Buy And Merger Exit

US Foods Holding (NYSE:USFD) signs a definitive agreement to acquire Shetakis, expanding its presence in the foodservice distribution space. The company ends its planned merger with Performance Foods after running into regulatory and economic hurdles. Together, these moves reshape US Foods Holding's growth playbook in a challenging foodservice market. US Foods Holding, one of the largest foodservice distributors in the US, operates in a sector facing cost pressures, changing restaurant...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

US Stock Market Today Stock Futures Edge Lower On Housing Jitters And Fed Uncertainty

The Morning Bull - US Market Morning Update Wednesday, Mar, 11 2026 US stock futures are slightly lower this morning, with E-mini S&P 500 contracts down about 0.1%, as investors weigh softer US housing confidence against steady bond markets and solid hiring. Existing home sales are running at an annual pace of 4.09 million, with prices near US$398,000, which matters for anyone thinking about moving or taking out a new mortgage. At the same time, the 10 year Treasury yield is holding around...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

Zevra Therapeutics (ZVRA) Profit Swing To US$77.6m TTM Tests Rare Disease Bull Case

Zevra Therapeutics (ZVRA) has wrapped up FY 2025 with Q4 total revenue of US$34.1 million and basic EPS of US$0.21, while trailing twelve month figures show total revenue of US$106.5 million and basic EPS of US$1.40. Over the past year, the company has seen total revenue move from US$23.6 million on a trailing basis in Q4 2024 to US$106.5 million by Q4 2025, alongside a shift from a trailing net loss of US$105.5 million to trailing net income of US$77.6 million. This sets the stage for a more...
NYSE:STNG
NYSE:STNGOil and Gas

Scorpio Tankers Refines Fleet Mix With Vessel Sales And Long Charters

Scorpio Tankers (NYSE:STNG) has agreed to sell three product tankers built in 2015. The company has also entered into multi year time charter agreements for two LR2 product tankers. These moves affect Scorpio Tankers' fleet mix, contracted revenue visibility, and use of capital. Scorpio Tankers, trading at $75.29, has seen its share price gain 51.5% year to date and 104.1% over the past year, with a 356.9% return over five years. In that context, changes to the fleet and contract profile...
NasdaqCM:PROP
NasdaqCM:PROPOil and Gas

A Look At Prairie Operating (PROP) Valuation As Leadership Shake-Up Raises Questions On Future Direction

Prairie Operating (PROP) is back in focus after a sweeping leadership reshuffle, including the resignation of CEO Edward Kovalik, the retirement of President Gary C. Hanna, and new interim appointments at the top. See our latest analysis for Prairie Operating. Those leadership changes arrive after a mixed stretch for investors, with the latest share price at $1.90, a 7 day share price return of 15.15% and a 1 year total shareholder return decline of 70.99%. This signals fading longer term...
NYSE:RNG
NYSE:RNGSoftware

RingCentral AIR Pro Launch Puts AI Healthcare Agents In Investor Focus

RingCentral has launched RingCentral AIR Pro, an AI powered, voice first omnichannel agent platform. The platform offers a no code environment for building and deploying digital agents across channels. AIR Pro debuts with healthcare focused capabilities, including support for integrations with major electronic health record systems. RingCentral, traded as NYSE:RNG, is introducing AIR Pro at a time when its shares trade around $40.69. The stock has seen strong recent momentum, with returns...
NYSE:YALA
NYSE:YALAInteractive Media and Services

Yalla Group (YALA) Margins Above 40% Challenge Market Skepticism On Slower Growth Guidance

Yalla Group (YALA) has rounded out FY 2025 with fourth quarter revenue of about US$83.9 million and basic EPS of US$0.23, against a trailing twelve month EPS of US$0.96 that sits alongside earnings growth of 10.4% year on year. Over the past six quarters in the dataset, revenue has moved within a tight band between roughly US$83.9 million and US$90.8 million per quarter, while quarterly EPS has ranged from about US$0.20 to US$0.27, feeding into a trailing net profit margin of 43.8% that is...
NYSE:KRO
NYSE:KROChemicals

Kronos Worldwide (KRO) Q4 Loss Deepens To US$0.72 EPS And Tests Profit-Recovery Hopes

Kronos Worldwide (KRO) closed out FY 2025 with Q4 revenue of US$418.3 million and a basic EPS loss of US$0.72, capping off a trailing twelve month period where revenue totaled US$1.9 billion and basic EPS came in at a loss of US$0.96. Over recent quarters, the company has seen revenue move from US$423.1 million and basic EPS of a US$0.11 loss in Q4 2024 to US$489.8 million with EPS of US$0.16 in Q1 2025, before stepping down to US$456.9 million and a US$0.32 loss in Q3 2025 and ending at...
NasdaqGS:AMBA
NasdaqGS:AMBASemiconductor

Is There Now An Opportunity In Ambarella (AMBA) After Recent Share Price Weakness

If you are wondering whether Ambarella's current share price offers value or just more volatility, you are not alone and this article is here to help you weigh that up clearly. The stock last closed at US$54.00, with returns of a 4.5% decline over 7 days, a 17.2% decline over 30 days, a 28.2% decline year to date, a 3.8% gain over 1 year, a 29.5% decline over 3 years and a 51.2% decline over 5 years. Taken together, this gives you a mixed picture of short term pressure and longer term swings...
NasdaqGS:MGNX
NasdaqGS:MGNXBiotechs

MacroGenics (MGNX) Loss Of US$74.6 Million Tests Bullish Loss‑Narrowing Narrative

MacroGenics (MGNX) has wrapped up FY 2025 with fourth quarter revenue of US$41.2 million and a basic EPS loss of US$0.22, as the market weighs these results against a share price of US$3.43. The company has seen revenue move from US$110.7 million in Q3 2024 to US$72.8 million in Q3 2025, while basic EPS shifted from a profit of US$0.90 to a profit of US$0.27 over the same period, creating a mixed picture on topline scale and per share results. Overall, margins remain under pressure, which...
NasdaqGS:TTAN
NasdaqGS:TTANSoftware

Is It Time To Reassess ServiceTitan (TTAN) After Its Recent Share Price Pullback?

This article is designed to help you think about whether ServiceTitan is starting to look like good value or remains priced for high expectations. The stock recently closed at US$77.90, with returns of 2.8% over 7 days and 22.2% over 30 days, while year to date it shows a 23.3% decline and a 1-year return of an 8.4% decline. Recent news coverage has focused on ServiceTitan as a key software provider for trades and home services companies, highlighting its role in helping contractors manage...
NasdaqCM:IRD
NasdaqCM:IRDBiotechs

Opus Genetics (IRD) Trailing US$49.6m Loss Reinforces Bearish Profitability Narrative

Opus Genetics (IRD) has reported FY 2025 results with Q4 revenue of US$3.9 million, a basic EPS loss of US$0.21, and a net income loss of US$16.5 million. The trailing twelve month figures show revenue of US$14.2 million, a basic EPS loss of US$0.80, and a net income loss of US$49.6 million. Over the recent quarters in FY 2025, the company has reported revenue between US$2.9 million and US$4.4 million, while quarterly basic EPS losses have ranged from US$0.12 to US$0.25 per share. These...
NasdaqGS:GLRE
NasdaqGS:GLREInsurance

Greenlight Capital Re (GLRE) Q4 Combined Ratio Of 92.1% Tests Underwriting Quality Narratives

Greenlight Capital Re (GLRE) has wrapped up FY 2025 with fourth quarter revenue of US$210.5 million and basic EPS of US$1.47, capping a trailing 12 month period that delivered EPS of US$2.21 on revenue of US$721.3 million. Over the last few quarters, revenue has ranged from US$148.1 million to US$210.5 million, while quarterly EPS has swung between a loss of US$0.13 and a profit of US$1.47. This gives investors a fuller picture of how the year built to the latest result. With a trailing net...
NYSE:DLX
NYSE:DLXCommercial Services

Deluxe Board Change Raises Questions For Payments And Cloud Transition

Deluxe (NYSE:DLX) has announced that Director Cheryl E. Mayberry McKissack will step down from its board and will not stand for re election. The board change is scheduled to take effect at the company’s upcoming annual meeting. For shareholders watching Deluxe, a company involved in payments, cloud, and data driven marketing services, board composition is one of the levers that can influence long term priorities. As the broader payments and business services space continues to evolve,...
NYSE:GEF
NYSE:GEFPackaging

Can Greif (GEF) Still Shape Its Margin Story Through Fresh Price Hikes?

In early March 2026, Greif Inc. announced price increases of US$60 to US$70 per short ton on all uncoated recycled paperboard grades effective from April 6, alongside at least a 7.5% rise on tube, core, and protective packaging products from April 13, citing higher labor, utilities, manufacturing, and transport costs. This pricing move underscores Greif’s ability to pass through rising input costs across its recycled paperboard and converted packaging portfolio, which could influence...
NasdaqGS:KVHI
NasdaqGS:KVHICommunications

KVH Industries (KVHI) Q4 Profitability Return Challenges Persistent Loss Narrative

KVH Industries (KVHI) closed out FY 2025 with Q4 revenue of US$30.5 million and basic EPS of roughly US$0.02, alongside net income of about US$0.3 million. Over the past year, the company has seen quarterly revenue range from US$25.4 million to US$30.5 million, while basic EPS has swung between a loss of around US$0.36 in Q3 2025 and a profit of about US$0.05 in Q2 2025. This gives investors a clear view of how volatile margins have been. With trailing 12 month figures still pointing to an...
NYSE:FCPT
NYSE:FCPTSpecialized REITs

Four Corners Expands Auto Service Portfolio With Indiana And Texas Deals

Four Corners Property Trust (NYSE:FCPT) has acquired automotive service properties in Texas and Indiana. Each property is operated under a long term triple net lease with a national automotive service tenant. The transactions extend FCPT’s reach beyond casual dining into essential, car focused retail locations. For you as an investor, these new deals highlight how Four Corners Property Trust, known for its net lease portfolio centered on restaurants, is adding more automotive service assets...
NasdaqGM:CHRS
NasdaqGM:CHRSBiotechs

Coherus Oncology (CHRS) Revenue Gains Contrast With Persistent US$46 Million Quarterly Losses

Coherus Oncology (CHRS) just posted its FY 2025 numbers with Q4 revenue of US$12.7 million and a basic EPS loss of US$0.39, while trailing 12 month figures show revenue of US$42.2 million and a basic EPS loss of US$1.56. Over recent quarters, the company has seen revenue move from US$7.6 million in Q1 2025 to US$12.7 million in Q4 2025, with quarterly basic EPS losses in a tight band around US$0.38 to US$0.41. This keeps the focus squarely on how efficiently each extra dollar of sales is...
NasdaqGS:INVA
NasdaqGS:INVAPharmaceuticals

How Investors May Respond To Innoviva (INVA) Surging EPS From Continuing Operations

In February 2026, Innoviva, Inc. reported fourth-quarter 2025 revenue of US$114.61 million and net income of US$164.15 million, alongside full-year revenue of US$411.33 million and net income of US$271.17 million, all higher than the prior year. An interesting feature of this release is the sharp increase in basic earnings per share from continuing operations, with quarterly EPS rising to US$2.19 and full-year EPS reaching US$4.02 compared with the previous year. We’ll now explore how...
NYSE:RCUS
NYSE:RCUSBiotechs

Why Arcus Biosciences (RCUS) Is Up 9.5% After New Casdatifan Data And Pipeline Expansion

Arcus Biosciences recently reported full-year 2025 results, with revenue of US$247 million versus US$258 million in 2024 and a net loss of US$353 million, while also granting new employee equity awards under its 2020 Inducement Plan. More importantly for the story, Arcus outlined encouraging new clinical data and expansion plans for its HIF-2α inhibitor casdatifan in kidney cancer, alongside moves into inflammatory and autoimmune diseases that could reshape how investors view its pipeline...
NasdaqGS:TLRY
NasdaqGS:TLRYPharmaceuticals

Tilray’s BrewDog Australia Deal Expands Asia Pacific Reach Amid Weak Shares

Tilray Brands has completed its acquisition of BrewDog Brewing Australia, expanding its beverage platform into the Asia Pacific region. The deal adds an Australian production facility, bar network, and new distribution channels to Tilray’s existing BrewDog UK relationship. This move is described by the company as its most significant international step in beverages so far. Tilray Brands, traded as NasdaqGS:TLRY, now pairs its existing BrewDog UK exposure with a direct operating footprint in...
NYSE:OPLN
NYSE:OPLNCommercial Services

Assessing OPENLANE (OPLN) Valuation As Contrasting Fair Value And DCF Signals Emerge

OPENLANE (OPLN) has drawn investor attention after recently trading around US$28.34. Its mixed share performance over the past month and past 3 months has prompted closer scrutiny of its wholesale used vehicle marketplace business. See our latest analysis for OPENLANE. Looking beyond the recent pullback, OPENLANE’s 1 day share price return of 1.73% and 30 day share price return of a 3.70% decline contrast with a 1 year total shareholder return of 36.58% and 3 year total shareholder return of...
NYSE:KSS
NYSE:KSSMultiline Retail

Kohl’s (KSS) Thin 1.8% Net Margin Tests Bullish Earnings Rebound Narrative

Kohl's (KSS) has wrapped up FY 2026 with fourth quarter revenue of US$5,173 million and basic EPS of US$1.12, anchored by net income of US$125 million. Trailing 12 month basic EPS sits at US$2.43 on revenue of US$15,527 million. Over the past few quarters, the company has seen quarterly revenue move from US$3,233 million in Q1 2026 to US$5,173 million in Q4 2026, with basic EPS ranging from a loss of US$0.14 in Q1 2026 to US$1.12 in Q4 2026. Trailing 12 month EPS has risen from US$1.09 at Q1...
NasdaqCM:RPAY
NasdaqCM:RPAYDiversified Financial

Repay Holdings RPAY Loss Deepens To US$3.00 TTM EPS Challenging Margin Recovery Narratives

Repay Holdings FY 2025 results: revenue steady, losses weigh on margins Repay Holdings (RPAY) has wrapped up FY 2025 with Q4 revenue of US$78.6 million and a basic EPS loss of US$1.71, capping a year in which trailing 12 month revenue came in at US$309.3 million alongside a net loss of US$256.7 million. Over recent quarters the company has seen quarterly revenue move in a tight band between US$75.6 million and US$79.1 million, while quarterly basic EPS has ranged from a loss of US$1.71 to a...